Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Vaniqa Rx Facial Hair Remover May Be Strong OTC Switch Candidate

This article was originally published in The Tan Sheet

Executive Summary

Ongoing studies of Bristol-Myers Squibb's newly approved Vaniqa prescription hair removal drug could broaden the topical cream's target population to include men. FDA approved the product for removal of women's facial hair July 27.

You may also be interested in...



OTC Vaniqa Could Surface By Early 2005

Women First HealthCare may explore Rx-to-OTC switch opportunities forVaniqa facial hair growth retardation cream as early as 2004, the firm stated

OTC Vaniqa Could Surface By Early 2005

Women First HealthCare may explore Rx-to-OTC switch opportunities forVaniqa facial hair growth retardation cream as early as 2004, the firm stated

BMS Mead Johnson Impending Changes Continue Reorganization Efforts

An organizational shakeup at Mead Johnson is being executed by parent Bristol-Myers Squibb to help reverse disappointing results in recent quarters at the nutritionals division.

Related Content

Topics

UsernamePublicRestriction

Register

PS091527

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel